Journal
ADVANCES IN RADIATION ONCOLOGY
Volume 5, Issue 4, Pages 743-745Publisher
ELSEVIER INC
DOI: 10.1016/j.adro.2020.04.040
Keywords
-
Ask authors/readers for more resources
We describe the institutional guidelines of a major tertiary cancer center with regard to using hypofractionated radiation regimens to treat glioblastoma as a measure to minimize exposure to coronavirus disease 2019 (COVID-19) while not sacrificing clinical outcomes. Our guidelines review level one evidence of various hypofractionated regimens, and recommend a multidisciplinary approach while balancing the risk of morbidity and mortality among individuals at high risk for severe illness from COVID-19 infection. We also briefly outline strategies our department is taking in mitigating risk among our cancer patients undergoing radiation. (C) 2020 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available